Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Handgraaf SM"'
Autor:
Kloosterman DJ; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Erbani J; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Boon M; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Farber M; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Handgraaf SM; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Ando-Kuri M; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Sánchez-López E; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Fontein B; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Mertz M; Bioimaging Facility, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Nieuwland M; Genomics Core Facility, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Liu NQ; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Forn-Cuni G; Institute of Biology Leiden, Leiden University, Leiden, the Netherlands., van der Wel NN; Electron Microscopy Centre Amsterdam, Medical Biology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Grootemaat AE; Electron Microscopy Centre Amsterdam, Medical Biology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Reinalda L; The Institute of Chemical Immunology, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., van Kasteren SI; The Institute of Chemical Immunology, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., de Wit E; Division of Gene Regulation, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Ruffell B; Department of Immunology, Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Snaar-Jagalska E; Institute of Biology Leiden, Leiden University, Leiden, the Netherlands., Petrecca K; Montreal Neurological Institute-Hospital, McGill University Health Centre and Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC, Canada., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066CX Amsterdam, the Netherlands., Kros A; Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., Giera M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Akkari L; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands. Electronic address: l.akkari@nki.nl.
Publikováno v:
Cell [Cell] 2024 Sep 19; Vol. 187 (19), pp. 5336-5356.e30. Date of Electronic Publication: 2024 Aug 12.
Autor:
van Hooren L; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Handgraaf SM; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kloosterman DJ; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Karimi E; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., van Mil LWHG; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Gassama AA; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Solsona BG; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Groot MHP; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Quail DF; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Physiology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Walsh LA; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., Borst GR; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health and Manchester Cancer Research Centre, University of Manchester, Manchester, UK. gerben.borst@nhs.net.; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK. gerben.borst@nhs.net., Akkari L; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. l.akkari@nki.nl.
Publikováno v:
Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 665-681. Date of Electronic Publication: 2023 Apr 20.
Autor:
Akkari L; Department of Oncology, University of Lausanne, 1011 Lausanne, Switzerland. johanna.joyce@unil.ch l.akkari@nki.nl.; Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland.; Tumor Biology and Immunology Division, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066CX, Netherlands., Bowman RL; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Tessier J; Tumor Biology and Immunology Division, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066CX, Netherlands., Klemm F; Department of Oncology, University of Lausanne, 1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland., Handgraaf SM; Tumor Biology and Immunology Division, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066CX, Netherlands., de Groot M; Tumor Biology and Immunology Division, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066CX, Netherlands., Quail DF; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Tillard L; Department of Oncology, University of Lausanne, 1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland., Gadiot J; Tumor Biology and Immunology Division, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066CX, Netherlands., Huse JT; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Brandsma D; Departments of Neuro-Oncology and Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam 1066CX, Netherlands., Westerga J; Departments of Neuro-Oncology and Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam 1066CX, Netherlands., Watts C; Birmingham Brain Cancer Program, Institute of Cancer Genome Sciences, University of Birmingham, Birmingham B15 2TT, UK., Joyce JA; Department of Oncology, University of Lausanne, 1011 Lausanne, Switzerland. johanna.joyce@unil.ch l.akkari@nki.nl.; Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 Jul 15; Vol. 12 (552).
Autor:
Clijsters L; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Perlmutter NYU Cancer Center, New York University School of Medicine, New York, NY 10016, USA., Hoencamp C; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Perlmutter NYU Cancer Center, New York University School of Medicine, New York, NY 10016, USA., Calis JJA; Program of Immunogenomics, The Rockefeller University, New York, NY 10065, USA., Marzio A; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Perlmutter NYU Cancer Center, New York University School of Medicine, New York, NY 10016, USA., Handgraaf SM; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Perlmutter NYU Cancer Center, New York University School of Medicine, New York, NY 10016, USA., Cuitino MC; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA., Rosenberg BR; Program of Immunogenomics, The Rockefeller University, New York, NY 10065, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Leone G; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA., Pagano M; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Perlmutter NYU Cancer Center, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, New York University School of Medicine, New York, NY 10016, USA. Electronic address: michele.pagano@nyumc.org.
Publikováno v:
Molecular cell [Mol Cell] 2019 Jun 20; Vol. 74 (6), pp. 1264-1277.e7. Date of Electronic Publication: 2019 May 23.